Skip to main content
logo
Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
6.06
+0.12 (2.02%)
At close: Aug 12, 2026, 4:00 PM EDT
5.98
-0.08 (-1.32%)
After-hours: Aug 12, 2026, 7:52 PM EDT

UPC Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
17.7417.8623.0232.3140.1447.98
Revenue Growth
-0.65%-22.44%-28.74%-19.52%-16.34%56.27%
Gross Profit
6.486.36.0710.3221.8925.33
Operating Income
-2.09-2.92-8.02-3.97-7.0213.59
Net Income
-1.94-3.67-8.73-6.58-7.9111.32
Earnings Per Share
-1.38-8.06-626.96---
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Investments
29.0533.5929.55.2918.8621.8
Total Debt
9.559.267.995.483.944.33
Net Cash (Debt)
19.524.3421.5-0.214.9217.47
Net Cash Growth
-19.88%13.17%---14.57%135.67%
Net Cash Per Share
34.5953.381544.79---

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
-11.91-5.05-9.511.12-1.3-2.06
Capital Expenditures
-0.48-0.27-0.25-0.04-0.09-13.53
Free Cash Flow
-12.39-5.32-9.751.07-1.39-15.59
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Gross Margin
36.52%35.28%26.37%31.93%54.53%52.78%
Operating Margin
-11.78%-16.33%-34.83%-12.28%-17.49%28.32%
Pretax Margin
-10.95%-20.56%-35.27%-13.39%-17.67%28.51%
Profit Margin
-10.95%-20.56%-32.63%-6.42%-15.64%33.42%
FCF Margin
-69.85%-29.78%-42.36%3.32%-3.47%-32.49%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
P/FCF Ratio
---3.21--
PS Ratio
0.220.130.270.110.311.12